Nanomedicines for kidney diseases
Ryan M Williams1, Edgar A Jaimes2, Daniel A Heller2
1Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Kidney International
|June 14, 2016
Summary
Nanomedicines offer targeted drug delivery for diseases. This review explores nanomaterial applications for kidney disorders, addressing unmet clinical needs.
Area of Science:
- Biomedical Engineering
- Materials Science
- Nephrology
Background:
- Nanomedicines are increasingly used in medicine for targeted drug delivery, improved solubility, and diagnostics.
- Few nanomedicine applications currently focus on kidney disorders, representing a significant gap in treatment options.
Purpose of the Study:
- To review nanomaterial properties relevant to kidney research and therapy.
- To identify clinical needs in nephrology that could benefit from nanomedicine interventions.
Main Methods:
- Literature review of nanomaterials and their properties.
- Analysis of current clinical applications of nanomedicine.
- Identification of potential applications in kidney disease treatment and diagnosis.
Main Results:
- Nanomaterials offer enhanced drug solubility and targeted delivery, reducing side effects.
- Various nanomaterials possess properties suitable for kidney research and therapeutic applications.
- Significant potential exists for nanomedicines to address unmet needs in nephrology.
Conclusions:
- Nanomedicine holds promise for advancing kidney disease treatment and diagnosis.
- Further research into kidney-specific nanomedicines is warranted.
- Targeted delivery and improved diagnostics are key benefits for nephrology.
Related Concept Videos
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
455
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
455
01:28Chronic Kidney Disease III: Interprofessional Care
586
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
586
01:10Nephrons
8.3K
The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
8.3K
01:20Acute Kidney Injury V: Interprofessional Care
450
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
450
01:25Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
91
The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
91
01:28Renal Drug Excretion: Tubular Secretion
1.1K
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
1.1K